Close
  Indian J Med Microbiol
 

Figure 2: (a) (A) Distribution of obstructive coronary artery disease in patients of non-ST-elevation acute coronary syndromes (n = 216/324), (B) distribution of single vessel disease in patients of obstructive coronary ar tery disease with non-ST-elevation acute coronary syndromes (n = 152/216), (C) involvement of coronary arteries in patients of single vessel disease with non-ST-elevation acute coronary syndromes (n = 152); (b) distribution of mode of death among patients of non-ST-elevation acute coronary syndromes (n = 24); (c) distribution of complications in patients of non-ST-elevation acute coronary syndromes (n = 348); (d) distribution of treatments advised in patients of non-ST-elevation acute coronary syndromes (n = 324); (e) distribution of coronary artery diseases among patients of non-ST-elevation acute coronary syndromes with respect to GRACE RISK SCORE.

Figure 2: (a) (A) Distribution of obstructive coronary artery disease in patients of non-ST-elevation acute coronary syndromes (<i>n</i> = 216/324), (B) distribution of single vessel disease in patients of obstructive coronary ar tery disease with non-ST-elevation acute coronary syndromes (<i>n</i> = 152/216), (C) involvement of coronary arteries in patients of single vessel disease with non-ST-elevation acute coronary syndromes (<i>n</i> = 152); (b) distribution of mode of death among patients of non-ST-elevation acute coronary syndromes (<i>n</i> = 24); (c) distribution of complications in patients of non-ST-elevation acute coronary syndromes (<i>n</i> = 348); (d) distribution of treatments advised in patients of non-ST-elevation acute coronary syndromes (<i>n</i> = 324); (e) distribution of coronary artery diseases among patients of non-ST-elevation acute coronary syndromes with respect to GRACE RISK SCORE.